Clinical Trial Update: Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial evaluating the long-term safety of intravenous vedolizumab in children with ulcerative colitis or Crohn's disease; results were complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Ulcerative Colitis, Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-03-13